...its advanced program in Fabry disease closer to approval. Escolar was CMO at miRagen.Ann Arbor-based ONL Therapeutics Inc....
...research at Acceleron Pharma Inc. (NASDAQ:XLRN).TARGETSFASN (FAS) – Fatty acid synthase BC Staff Dynavax Technologies Corp. Avrobio Inc. Imago BioSciences Inc. ONL Therapeutics Inc. miRagen...

...Capital, PSQ Capital and Michigan Capital Network Venture Fund III. Existing investors in round included ONL Therapeutics...

...Homcy, who will become chairman. Homcy is a partner at Third Rock. Retinal disease company ONL Therapeutics Inc....
...Block, Associate Editor Arbutus Biopharma Arbutus Biopharma Corp. F-star Biotechnology F-star Biotechnology Ltd. Maze Therapeutics Menlo Therapeutics Menlo Therapeutics Inc. Millendo Therapeutics Millendo Therapeutics Inc. ONL Therapeutics ONL Therapeutics Inc. Ultragenyx Ultragenyx...

...also has the product in Phase I testing for myelodysplastic syndrome (MDS) and solid tumors. ONL Therapeutics Inc....

...On May 17, ophthalmic company ONL Therapeutics Inc. (Ann Arbor, Mich.) raised $4.3 million in a series A...
...Michigan, Biosciences Research & Commercialization Center and Hestia Investments. ONL Therapeutics Inc. , Ann Arbor, Mich. Mary Romeo Novartis AG ONL Therapeutics Inc. University...

...On March 21, retinal disease company ONL Therapeutics Inc. (Ann Arbor, Mich.) said it recently raised more than...
...investors, including Novartis AG and Invest Michigan, and existing investors. ONL Therapeutics Inc. , Ann Arbor, Mich. Alex Himes ONL Therapeutics Inc....

...Michigan and MEEI. Companies and Institutions Mentioned Massachusetts Eye and Ear Infirmary , Boston, Mass. ONL Therapeutics...
...Ann Arbor, Mich. University of Michigan Kellogg Eye Center , Ann Arbor, Mich. Sidebars ONL Therapeutics...